MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517067620 A) filed by Astrazeneca AB, Sodertalje, Sweden, on July 15, for '2,6,9-trisubstituted purines.'
Inventor(s) include Barlaam, Bernard; Bodnarchuk, Michael; Ghosh, Avipsa; Goldberg, Frederick; Hande, Sudhir; Lichtor, Phillip; Song, Kun; Su, Qibin; Telmesani, Reem; and Sheppeck, James.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "Compounds having the structure of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are as defined in the specification; pharmaceutical compositions comprising such compounds and salts; use of such compounds and salts to treat or prevent cyclin-dependent kinase 2 (CDK2)-mediated conditions; kits comprising such compounds and salts; and methods for manufacturing such compounds and salts."
The patent application was internationally filed on Dec. 15, 2023, under International application No.PCT/IB2023/062789.
Disclaimer: Curated by HT Syndication.
